VOGLINORM M 0.3 TAB

About

Voglinorm M 0.3 Tab is a combination medication containing Voglibose and Metformin, formulated for the effective management of type 2 diabetes mellitus. Voglibose, an alpha-glucosidase inhibitor, works by delaying the breakdown and absorption of carbohydrates in the small intestine, thereby significantly reducing the rise in blood glucose levels that occurs after meals (post-prandial hyperglycemia). This action helps to flatten the post-meal glucose curve and improve overall glycemic control.

Metformin, a biguanide, complements Voglibose by primarily decreasing glucose production in the liver and enhancing insulin sensitivity in peripheral tissues, allowing the body's own insulin to work more efficiently. It also reduces glucose absorption from the gastrointestinal tract. The dual mechanism of action addresses both post-meal glucose spikes and basal glucose levels, leading to a more comprehensive and sustained reduction in blood sugar and HbA1c. This combination is particularly beneficial for patients who require improved glycemic control beyond what can be achieved with monotherapy.

Uses

• Management of type 2 diabetes mellitus.
• Reduction of post-prandial hyperglycemia.
• Improved fasting and post-meal blood glucose.
• Used when monotherapy is insufficient.

Directions For Use

Take this medication orally, usually with meals, as directed by your healthcare provider. Swallow the tablet whole with water.

Benefits

• Provides dual action for comprehensive glucose control.
• Effectively lowers both post-meal and fasting blood sugar.
• Reduces HbA1c levels significantly.
• Helps improve insulin sensitivity.
• Generally associated with weight neutrality or modest weight loss.
• Reduces the risk of long-term diabetes complications.

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Flatulence
• Metallic taste in mouth
• Indigestion
• Headache
• Dizziness
• Vitamin B12 deficiency (long-term Metformin use)
• Skin rash
• Lactic acidosis (rare, serious with Metformin)
• Hypoglycemia (rare, when used with other agents)

Safety Measures

• Alcohol - Alcohol can increase the risk of hypoglycemia and lactic acidosis (with Metformin). Limit or avoid alcohol consumption.
• Pregnancy - Not recommended during pregnancy. Insulin is often preferred for glycemic control in pregnant diabetic women. Consult your doctor.
• Breastfeeding - Avoid use during breastfeeding as Metformin can pass into breast milk. Insufficient data for Voglibose.
• Liver - Use with caution in patients with liver impairment, especially due to Metformin. Regular monitoring is advised.
• Kidney - Contraindicated in severe renal impairment due to Metformin's risk of lactic acidosis. Dose adjustment is necessary for moderate impairment.
• Lung - No specific contraindications related to lung conditions, but severe respiratory failure can increase lactic acidosis risk with Metformin.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.